Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database

Abstract

Obesity is associated with increased risk of positive surgical margins and prostate specific antigen (PSA) recurrence among men undergoing radical prostatectomy. To what degree positive margins contribute to poorer outcome is unclear. Thus, we sought to examine the association between body mass index (BMI) and more objective measures of tumor aggressiveness, tumor grade and size. We carried out a retrospective analysis of 2302 patients treated with radical prostatectomy at the Duke Prostate Center from 1988–2007. Tumor volume was calculated by multiplying prostate weight by percent of specimen involved with cancer. Associations between BMI and tumor volume and high-grade disease (Gleason4+3) independent of pre-operative clinical characteristics of age, race, PSA, clinical stage, biopsy Gleason sum, and year of surgery were assessed using linear and logistic regression, respectively. Mean and median BMI among all subjects was 28.1 and 27.6 kg m–2, respectively. Increased BMI was significantly associated with younger age (P<0.001), black race (P<0.001), more recent year of surgery (P<0.001), and positive surgical margins (P<0.001). After adjusting for multiple clinical pre-operative characteristics, higher BMI was associated with a greater percent of the prostate involved with cancer (P=0.003), increased tumor volume (P<0.001), and high-grade disease (P=0.007). Men with a BMI 35 kg m2 had nearly 40% larger mean tumor volumes than normal weight men (5.1 versus 3.7 cc), after adjustment for multiple clinical characteristics. In this study, obese men undergoing radical prostatectomy had higher-grade and larger tumors, providing further evidence that obese men undergoing radical prostatectomy have more aggressive prostate cancers.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Freedland SJ, Grubb KA, Yiu SK, Humphreys EB, Nielsen ME, Mangold LA et al. Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center. J Urol 2005; 174: 919–922.

    Article  PubMed  Google Scholar 

  2. Amling CL, Riffenburgh RH, Sun L, Moul JW, Lance RS, Kusuda L et al. Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol 2004; 22: 439–445.

    Article  PubMed  Google Scholar 

  3. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ . Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625–1638.

    Article  PubMed  Google Scholar 

  4. Freedland SJ, Grubb KA, Yiu SK, Nielsen ME, Mangold LA, Isaacs WB et al. Obesity and capsular incision at the time of open retropubic radical prostatectomy. J Urol 2005; 174: 1798–1801.

    Article  PubMed  Google Scholar 

  5. Jayachandran J, Aronson WJ, Terris MK, Presti Jr JC, Amling CL, Kane CJ et al. Obesity and positive surgical margins by anatomic location after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database. BJU Int 2008.

  6. Davies BJ, Walsh TJ, Ross PL, Knight SJ, Sadetsky N, Carroll PR et al. Effect of BMI on primary treatment of prostate cancer. Urology 2008; 72: 406–411.

    Article  PubMed  Google Scholar 

  7. Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS et al. Survival following primary androgen deprivation therapy among men with localized prostate cancer. JAMA 2008; 300: 173–181.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Wong YN, Mitra N, Hudes G, Localio R, Schwartz JS, Wan F et al. Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA 2006; 296: 2683–2693.

    Article  CAS  PubMed  Google Scholar 

  9. Freedland SJ, Giovannucci E, Platz EA . Are findings from studies of obesity and prostate cancer really in conflict? Cancer Causes Control 2006; 17: 5–9.

    Article  PubMed  Google Scholar 

  10. Freedland SJ, Sun L, Kane CJ, Presti Jr JC, Terris MK, Amling CL et al. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. BJU Int 2008; 102: 969–974.

    Article  PubMed  Google Scholar 

  11. Rampersaud EN, Sun L, Moul JW, Madden J, Freedland SJ . Percent tumor involvement and risk of biochemical progression after radical prostatectomy. J Urol 2008; 180: 571–576 discussion 576.

    Article  PubMed  Google Scholar 

  12. Freedland SJ, Terris MK, Platz EA, Presti Jr JC . Body mass index as a predictor of prostate cancer: development versus detection on biopsy. Urology 2005; 66: 108–113.

    Article  PubMed  Google Scholar 

  13. Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW et al. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 2006; 15: 1977–1983.

    Article  PubMed  Google Scholar 

  14. Loeb S, Yu X, Nadler RB, Roehl KA, Han M, Hawkins SA et al. Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy? J Urol 2007; 177: 102–106; discussion 106.

    Article  PubMed  Google Scholar 

  15. Hammarsten J, Hogstedt B . Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 2001; 39: 151–158.

    Article  CAS  PubMed  Google Scholar 

  16. Bray GA . The underlying basis for obesity: relationship to cancer. J Nutr 2002; 132: 3451S–3455S.

    Article  CAS  PubMed  Google Scholar 

  17. Cox ME, Gleave ME, Zakikhani M, Bell RH, Piura E, Vickers E et al. Insulin receptor expression by human prostate cancers. Prostate 2009; 69: 33–40.

    Article  CAS  PubMed  Google Scholar 

  18. Ma J, Li H, Giovannucci E, Mucci L, Qiu W, Nguyen PL et al. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol 2008; 9: 1039–1047.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Hammarsten J, Hogstedt B . Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Eur J Cancer 2005; 41: 2887–2895.

    Article  CAS  PubMed  Google Scholar 

  20. Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ et al. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiol Biomarkers Prev 2005; 14: 1262–1269.

    Article  CAS  PubMed  Google Scholar 

  21. Chan JM, Gann PH, Giovannucci EL . Role of diet in prostate cancer development and progression. J Clin Oncol 2005; 23: 8152–8160.

    Article  CAS  PubMed  Google Scholar 

  22. Banez LL, Hamilton RJ, Partin AW, Vollmer RT, Sun L, Rodriguez C et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 2007; 298: 2275–2280.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Supported by the Division of Urologic Surgery and Department of Surgery, Duke University School of Medicine, Department of Defense Prostate Cancer Research Program (SJF and LLB), and the American Urological Association Foundation Astellas Rising Star in Urology Award (SJF). Views and opinions of, and endorsements by the author(s) do not reflect those of the US Army or the Department of Defense.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S J Freedland.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Freedland, S., Bañez, L., Sun, L. et al. Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database. Prostate Cancer Prostatic Dis 12, 259–263 (2009). https://doi.org/10.1038/pcan.2009.11

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/pcan.2009.11

Keywords

This article is cited by

Search

Quick links